Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 14, 2022
Bangyao Biological
|
Series B | — | Biopharma | — |
Nov 26, 2021
Reading Technology
|
Series A | — | Artificial Intelligence | — |
May 6, 2021
Just Medical
|
Series B | ¥220M | Health Care | — |
Jan 1, 2016
Triastek
|
Seed | — | 3D Printing | Yes |